VWF-Factor VIII Polymer Conjugates with Hydrolyzable Linkage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering biologically active agents like polypeptides face challenges such as short half-life, immunogenicity, and the need for frequent injections, with existing polymer conjugation techniques sometimes compromising pharmacologic activity due to steric effects and reliance on enzymatic processes for release.
Innovation Solution
Development of conjugates with a releasable linkage, specifically a von Willebrand Factor or Factor VIII moiety linked to water-soluble polymers via a hydrolyzable bond, allowing for increased in vivo half-life without enzymatic dependence, using a conjugate structure that includes a first and second water-soluble polymer, spacer moieties, and an ionizable hydrogen atom for controlled release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polypeptides are delivered via injection, then they can be introduced into systemic circulation without exposure to proteolytic environment, but they have relatively short half-life requiring repeated injections
Solution Approach 1:
The patent applies composite materials by conjugating polypeptide active agents with water-soluble polymer carriers to create hybrid conjugate molecules. This composite structure combines the biological activity of the polypeptide with the extended circulation properties of the polymer, thereby increasing half-life while maintaining delivery reliability
Solution Approach 2:
The water-soluble polymer acts as an intermediary carrier that mediates between the polypeptide active agent and the biological system. The polymer conjugate serves as an intermediate form that protects the polypeptide and extends its circulation time before releasing the active agent
2Duration of action of moving object
If polypeptides are conjugated to water-soluble polymers, then half-life is increased and immunogenicity is reduced, but pharmacologic activity may be compromised due to steric effects
Solution Approach 1:
The patent applies local quality by strategically positioning the polymer conjugation at specific sites on the polypeptide molecule that are distal to the pharmacologically critical regions. This localized conjugation approach ensures that the polymer extends half-life while leaving the active sites accessible and maintaining pharmacologic activity
Solution Approach 2:
The patent uses spacer moieties as structural copies or proxies that maintain the necessary spatial separation between the polymer and the active site. The spacer acts as a surrogate structure that preserves the geometric requirements for activity while allowing polymer attachment
3Ease of operation
If enzymatic processes are used for release, then controlled release can be achieved, but the system becomes dependent on enzyme availability and activity
Solution Approach 1:
The patent applies parameter changes by designing release mechanisms based on environmental parameter variations such as pH gradients, redox conditions, or enzymatic activity levels. The conjugate structure incorporates linkers that respond to these parameter changes to trigger release, providing controlled release while adapting to different physiological conditions without strict enzyme dependence
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly increases the in vivo half-life of biologically active agents, reducing the frequency of injections and minimizing immunogenicity, while maintaining pharmacologic activity by enabling controlled release through hydrolysis, thereby improving therapeutic efficacy.
Implementation Method 1
conjugates with a releasable linkage to thereby release the active agent in vivo
Data Source
AI summary
The present invention provides von Willebrand Factor-polymer conjugates and Factor VIII-polymer conjugates, each having a releasable linkage. Methods of making conjugates, methods for administering conjugates, are also provided.